» Articles » PMID: 35771225

Efficacy and Toxicity of the DPCPX Nanoconjugate Drug Study for the Treatment of Spinal Cord Injury in Rats

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Effects of the Adenosine A1 blockade using 8-cyclopentyl-1,3-diprophyxanthine (DPCPX) nanoconjugate on inducing recovery of the hemidiaphragm paralyzed by hemisection have been thoroughly examined previously; however, the toxicology of DPCPX nanoconjugate remains unknown. This research study investigates the therapeutic efficacy and toxicology of the nanoconjugate DPCPX in the cervical spinal cord injury (SCI) rat model. We hypothesized that a single injection of nanoconjugate DPCPX in the paralyzed left hemidiaphragm (LDH) of hemisected rats at the 2nd cervical segment (C2Hx) would lead to the long-term recovery of LDH while showing minimal toxicity. Adult male rats underwent left C2Hx surgery and the diaphragms' baseline electromyography (EMG). Subsequently, rats were randomized into a control group and four treated subgroups. Three subgroups received a single intradiaphragmatic dose of either 0.09, 0.15, or 0.27 µg/kg, and one subgroup received 0.1 mg/kg of native DPCPX two times per day intravenously (i.v.) for 3 days (total 0.6 mg/kg). Rats were monitored for a total of 56 days. Compared with control, the treatment with nanoconjugate DPCPX at 0.09 µg/kg, 0.15 µg/kg, and 0.27 µg/kg doses elicited significant recovery of paralyzed LDH (i.e., 67% recovery at 8 wk) ( < 0.05). DPCPX nanoconjugate-treated rats had significant weight loss for first 2 wk but recovered significantly by ( < 0.05). The levels of gold in the blood and body tissues were below the recommended levels. No sign of weakness, histology of tissue damage, or organ abnormality was observed. A dose of DPCPX nanoconjugate can induce long-term diaphragm recovery after SCI without observed toxicity. The intradiaphragmatic administration of nanoconjugate is safe and has the promise to significantly reduce the therapeutic dosage for the treatment and achieve long-term and possibly permanent recovery in respiratory muscle dysfunction after SCI. No toxicity of nanoconjugate was found in any of the experimental animals.

Citing Articles

Neural Tracing Protein-Functionalized Nanoparticles Capable of Fast Retrograde Axonal Transport in Live Neurons.

Wang W, Hassan M, Kapoor-Kaushik N, Livni L, Musrie B, Tang J Small. 2024; 20(39):e2311921.

PMID: 38647340 PMC: 11427170. DOI: 10.1002/smll.202311921.


Contrasting Experimental Rodent Aftercare With Human Clinical Treatment for Cervical Spinal Cord Injury: Bridging the Translational "Valley of Death".

Silverstein A, Lawson K, Farhadi H, Alilain W J Neurotrauma. 2023; 40(23-24):2469-2486.

PMID: 37772694 PMC: 10698787. DOI: 10.1089/neu.2023.0314.

References
1.
Heisler L, Lam D . An appetite for life: brain regulation of hunger and satiety. Curr Opin Pharmacol. 2017; 37:100-106. DOI: 10.1016/j.coph.2017.09.002. View

2.
Khlebtsov N, Dykman L . Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev. 2010; 40(3):1647-71. DOI: 10.1039/c0cs00018c. View

3.
Lasagna-Reeves C, Gonzalez-Romero D, Barria M, Olmedo I, Clos A, Ramanujam V . Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 2010; 393(4):649-55. DOI: 10.1016/j.bbrc.2010.02.046. View

4.
Minic Z, Wilson S, Liu F, Sankari A, Mao G, Goshgarian H . Nanoconjugate-bound adenosine A receptor antagonist enhances recovery of breathing following acute cervical spinal cord injury. Exp Neurol. 2017; 292:56-62. DOI: 10.1016/j.expneurol.2017.02.013. View

5.
Harada D, Takada C, Nosaka Y, Takashima Y, Kobayashi K, Takaba K . Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models. Int Immunopharmacol. 2008; 9(1):55-62. DOI: 10.1016/j.intimp.2008.09.011. View